Sandra Au
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandra Au has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Andrew S. Barbas
Department of Surgery, Duke University Medical Center, Durham, NC, USA
3 shared publications - Samantha E. Halpern
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
3 shared publications Christopher S. Klifto
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA
2 shared publications- Danae Olaso
Duke Transplant Center, Duke University School of Medicine, Durham, NC 27710, USA
2 shared publications - Daniel J. Cunningham
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA
2 shared publications - Heather E. Whitson
Department of Medicine (Division of Geriatric), Duke University School of Medicine, Durham, NC
2 shared publications
Latest Publications
- Open Access
- 1 October 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (10) , e01539
A Case of Immune Checkpoint Inhibitor–Induced Duodenitis
Immune checkpoint inhibitors improve patient survival in multiple cancers, but immune-related adverse events, including new immunologic conditions arising during therapy, pose a significant challenge. Gastrointestinal immune-related adverse events, although common, exhibit diverse presentations. We present a case of duodenitis resembling celiac disease because of the anti–programmed cell death protein-1 antibody, pembrolizumab. Despite diagnostic uncertainty and therapeutic interventions, including gluten-free diet, symptoms stabilized even with resuming gluten. In addition, endoscopic abnormalities after pembrolizumab therapy have neither progressed nor completely resolved. This case underscores the need for investigation into the pathogenesis of immune checkpoint inhibitor–induced duodenitis, with implications for care of patients on immunotherapies.
- 1 October 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (10) , e01539
Open AccessA Case of Immune Checkpoint Inhibitor–Induced Duodenitis
Immune checkpoint inhibitors improve patient survival in multiple cancers, but immune-related adverse events, including new immunologic conditions arising during therapy, pose a significant challenge. Gastrointestinal immune-related adverse events, although common, exhibit diverse presentations. We present a case of duodenitis resembling celiac disease because of the anti–programmed cell death protein-1 antibody, pembrolizumab. Despite diagnostic uncertainty and therapeutic interventions, including gluten-free diet, symptoms stabilized even with resuming gluten. In addition, endoscopic abnormalities after pembrolizumab therapy have neither progressed nor completely resolved. This case underscores the need for investigation into the pathogenesis of immune checkpoint inhibitor–induced duodenitis, with implications for care of patients on immunotherapies.
- Open Access
- 12 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 154-163
Preoperative electroencephalographic alpha-power changes with eyes opening are associated with postoperative attention impairment and inattention-related delirium severity
- 12 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 154-163
Open AccessPreoperative electroencephalographic alpha-power changes with eyes opening are associated with postoperative attention impairment and inattention-related delirium severity
- 1 February 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (2) , e83-e84
Response to Shen et al regarding “Regional anesthesia reduces inpatient and outpatient perioperative opioid demand in peri-articular elbow surgery”
- 1 February 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (2) , e83-e84
Response to Shen et al regarding “Regional anesthesia reduces inpatient and outpatient perioperative opioid demand in peri-articular elbow surgery”
- 1 February 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (2) , e48-e57
Regional anesthesia reduces inpatient and outpatient perioperative opioid demand in periarticular elbow surgery
- 1 February 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (2) , e48-e57
Regional anesthesia reduces inpatient and outpatient perioperative opioid demand in periarticular elbow surgery
- 9 January 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (4) , e14588
Textbook surgical outcome in lung transplantation: Analysis of a US national registry
Intro: Textbook surgical outcome (TO) is a novel composite quality measure in lung transplantation (LTx). Compared to 1‐year survival metrics, TO may better differentiate center performance, and motivate improvements in care. To understand the feasibility of implementing this metric, we defined TO in LTx using US national data, and evaluated its ability to predict post‐transplant outcomes and differentiate center performance.Methods: Adult patients who underwent isolated LTx between 2016 and 2019 were included. TO was defined as freedom from post‐transplant length of stay > 30 days, 90‐day mortality, intubation or extracorporeal membrane oxygenation at 72 h post‐transplant, post‐transplant ventilator support lasting ≥5 days, postoperative airway dehiscence, inpatient dialysis, pre‐discharge acute rejection, and grade 3 primary graft dysfunction at 72 h. Recipient and donor characteristics and post‐transplant outcomes were compared between patients who achieved and failed TO.Results: Of 8959 lung transplant recipients, 4664 (52.1%) achieved TO. Patient and graft survival were improved among patients who achieved TO (both log‐rank P < .0001). Among 62 centers, adjusted rates of TO ranged from 27.0% to 72.4% reflecting a wide variability in center‐level performance.Conclusion: TO defined using national data may represent a novel composite metric to guide quality improvement in LTx across US transplant centers.Summary: In this study we defined textbook outcome (TO) for lung transplantation (LTx) using US national data. We found that achievement of TO was associated with improved post‐transplant survival, and wide variability in center‐level LTx performance. These findings suggest that TO could be readily implemented to compare quality of care among US LTx centers.
- 9 January 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (4) , e14588
Textbook surgical outcome in lung transplantation: Analysis of a US national registry
Intro: Textbook surgical outcome (TO) is a novel composite quality measure in lung transplantation (LTx). Compared to 1‐year survival metrics, TO may better differentiate center performance, and motivate improvements in care. To understand the feasibility of implementing this metric, we defined TO in LTx using US national data, and evaluated its ability to predict post‐transplant outcomes and differentiate center performance.Methods: Adult patients who underwent isolated LTx between 2016 and 2019 were included. TO was defined as freedom from post‐transplant length of stay > 30 days, 90‐day mortality, intubation or extracorporeal membrane oxygenation at 72 h post‐transplant, post‐transplant ventilator support lasting ≥5 days, postoperative airway dehiscence, inpatient dialysis, pre‐discharge acute rejection, and grade 3 primary graft dysfunction at 72 h. Recipient and donor characteristics and post‐transplant outcomes were compared between patients who achieved and failed TO.Results: Of 8959 lung transplant recipients, 4664 (52.1%) achieved TO. Patient and graft survival were improved among patients who achieved TO (both log‐rank P < .0001). Among 62 centers, adjusted rates of TO ranged from 27.0% to 72.4% reflecting a wide variability in center‐level performance.Conclusion: TO defined using national data may represent a novel composite metric to guide quality improvement in LTx across US transplant centers.Summary: In this study we defined textbook outcome (TO) for lung transplantation (LTx) using US national data. We found that achievement of TO was associated with improved post‐transplant survival, and wide variability in center‐level LTx performance. These findings suggest that TO could be readily implemented to compare quality of care among US LTx centers.
- Open Access
- 11 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (2) , 552-564
Lung transplantation after ex vivo lung perfusion versus static cold storage: An institutional cost analysis
- 11 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (2) , 552-564
Open AccessLung transplantation after ex vivo lung perfusion versus static cold storage: An institutional cost analysis
- 29 July 2021
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 69 (11) , 3232-3241
A template for physical resilience research in older adults: Methods of the PRIME‐KNEE study
Background: Older adults with similar health conditions often experience widely divergent outcomes following health stressors. Variable recovery after a health stressor may be due in part to differences in biological mechanisms at the molecular, cellular, or system level, that are elicited in response to stressors. We describe the PRIME‐KNEE study as an example of ongoing research to validate provocative clinical tests and biomarkers that predict resilience to specific health stressors. Methods: PRIME‐KNEE is an ongoing, prospective cohort study that will enroll 250 adults ≥60 years undergoing total knee arthroplasty. Data are collected at baseline (pre‐surgery), during surgery, daily for 7 days after surgery, and at 1, 2, 4, and 6 months post‐surgery. Provocative tests include a cognition‐motor dual‐task walking test, cerebrovascular reactivity assessed by functional near‐infrared spectroscopy, peripheral blood mononuclear cell reactivity ex vivo to lipopolysaccharide toxin and influenza vaccine, and heart rate variability during surgery. Cognitive, psychological, and physical performance batteries are collected at baseline to estimate prestressor reserve. Demographics, medications, comorbidities, and stressor characteristics are abstracted from the electronic medical record and via participant interview. Blood‐based biomarkers are collected at baseline and postoperative day 1. Repeated measures after surgery include items from a delirium assessment tool and pain scales administered daily by telephone for 7 days and cognitive change index (participant and informant), lower extremity activities of daily living, pain scales, and step counts assessed by Garmin actigraphy at 1, 2, 4, and 6 months after surgery. Statistical models use these measures to characterize resilience phenotypes and evaluate prestressor clinical indicators associated with poststressor resilience. Conclusion: If PRIME‐KNEE validates feasible clinical tests and biomarkers that predict recovery trajectories in older surgical patients, these tools may inform surgical decision‐making, guide pre‐habilitation efforts, and elucidate mechanisms underlying resilience. This study design could motivate future geriatric research on resilience.
- 29 July 2021
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 69 (11) , 3232-3241
A template for physical resilience research in older adults: Methods of the PRIME‐KNEE study
Background: Older adults with similar health conditions often experience widely divergent outcomes following health stressors. Variable recovery after a health stressor may be due in part to differences in biological mechanisms at the molecular, cellular, or system level, that are elicited in response to stressors. We describe the PRIME‐KNEE study as an example of ongoing research to validate provocative clinical tests and biomarkers that predict resilience to specific health stressors. Methods: PRIME‐KNEE is an ongoing, prospective cohort study that will enroll 250 adults ≥60 years undergoing total knee arthroplasty. Data are collected at baseline (pre‐surgery), during surgery, daily for 7 days after surgery, and at 1, 2, 4, and 6 months post‐surgery. Provocative tests include a cognition‐motor dual‐task walking test, cerebrovascular reactivity assessed by functional near‐infrared spectroscopy, peripheral blood mononuclear cell reactivity ex vivo to lipopolysaccharide toxin and influenza vaccine, and heart rate variability during surgery. Cognitive, psychological, and physical performance batteries are collected at baseline to estimate prestressor reserve. Demographics, medications, comorbidities, and stressor characteristics are abstracted from the electronic medical record and via participant interview. Blood‐based biomarkers are collected at baseline and postoperative day 1. Repeated measures after surgery include items from a delirium assessment tool and pain scales administered daily by telephone for 7 days and cognitive change index (participant and informant), lower extremity activities of daily living, pain scales, and step counts assessed by Garmin actigraphy at 1, 2, 4, and 6 months after surgery. Statistical models use these measures to characterize resilience phenotypes and evaluate prestressor clinical indicators associated with poststressor resilience. Conclusion: If PRIME‐KNEE validates feasible clinical tests and biomarkers that predict recovery trajectories in older surgical patients, these tools may inform surgical decision‐making, guide pre‐habilitation efforts, and elucidate mechanisms underlying resilience. This study design could motivate future geriatric research on resilience.
- 14 July 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (8) , 1106-1115
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver‐Kidney Utilization and Outcomes
Historically in the United States, kidneys for simultaneous liver‐kidney transplantation (SLKT) candidates were allocated with livers, prioritizing SLKT recipients over much of the kidney waiting list. A 2017 change in policy delineated renal function criteria for SLKT and implemented a safety net for kidney‐after‐liver transplantation. We compared the use and outcomes of SLKT and kidney‐after‐liver transplant with the 2017 policy. United Network for Organ Sharing Standard Transplant Analysis and Research files were used to identify adults who received liver transplantations (LT) from August 10, 2007 to August 10, 2012; from August 11, 2012 to August 10, 2017; and from August 11, 2017 to June 12, 2019. LT recipients with end‐stage renal disease (ESRD) were defined by dialysis requirement or estimated glomerular filtration rate P = 0.01 ). There was also less variability in GFR at transplant after policy implementation on center and regional levels. We then evaluated LT‐alone (LTA) recipients with ESRD (n = 5408 from 2012‐2017; n = 2321 after the policy). Listing for a kidney within a year of LT increased from 2.9% before the policy change to 8.8% after the policy change, and the rate of kidney transplantation within 1 year increased from 0.7% to 4% (P < 0.001). After the policy change, there was no difference in patient survival rates between SLKT and LTA among patients with ESRD. Implementation of the 2017 SLKT policy change resulted in reduced variability in SLKT recipient kidney function and increased access to deceased donor kidney transplantation for LTA recipients with kidney disease without negatively affecting outcomes.
- 14 July 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (8) , 1106-1115
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver‐Kidney Utilization and Outcomes
Historically in the United States, kidneys for simultaneous liver‐kidney transplantation (SLKT) candidates were allocated with livers, prioritizing SLKT recipients over much of the kidney waiting list. A 2017 change in policy delineated renal function criteria for SLKT and implemented a safety net for kidney‐after‐liver transplantation. We compared the use and outcomes of SLKT and kidney‐after‐liver transplant with the 2017 policy. United Network for Organ Sharing Standard Transplant Analysis and Research files were used to identify adults who received liver transplantations (LT) from August 10, 2007 to August 10, 2012; from August 11, 2012 to August 10, 2017; and from August 11, 2017 to June 12, 2019. LT recipients with end‐stage renal disease (ESRD) were defined by dialysis requirement or estimated glomerular filtration rate P = 0.01 ). There was also less variability in GFR at transplant after policy implementation on center and regional levels. We then evaluated LT‐alone (LTA) recipients with ESRD (n = 5408 from 2012‐2017; n = 2321 after the policy). Listing for a kidney within a year of LT increased from 2.9% before the policy change to 8.8% after the policy change, and the rate of kidney transplantation within 1 year increased from 0.7% to 4% (P < 0.001). After the policy change, there was no difference in patient survival rates between SLKT and LTA among patients with ESRD. Implementation of the 2017 SLKT policy change resulted in reduced variability in SLKT recipient kidney function and increased access to deceased donor kidney transplantation for LTA recipients with kidney disease without negatively affecting outcomes.